These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26226998)

  • 1. Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense Mutation.
    Chowdhury R; Ashraf H; Melanson M; Tanada Y; Nguyen M; Silberbach M; Wakimoto H; Benson DW; Anderson RH; Kasahara H
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1255-64. PubMed ID: 26226998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation.
    Ashraf H; Pradhan L; Chang EI; Terada R; Ryan NJ; Briggs LE; Chowdhury R; Zárate MA; Sugi Y; Nam HJ; Benson DW; Anderson RH; Kasahara H
    Circ Cardiovasc Genet; 2014 Aug; 7(4):423-433. PubMed ID: 25028484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein.
    Kasahara H; Wakimoto H; Liu M; Maguire CT; Converso KL; Shioi T; Huang WY; Manning WJ; Paul D; Lawitts J; Berul CI; Izumo S
    J Clin Invest; 2001 Jul; 108(2):189-201. PubMed ID: 11457872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies.
    Kasahara H; Benson DW
    Cardiovasc Res; 2004 Oct; 64(1):40-51. PubMed ID: 15364612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmentally modulated cardiac conduction failure in transgenic mice with fetal or postnatal overexpression of DNA nonbinding mutant Nkx2.5.
    Wakimoto H; Kasahara H; Maguire CT; Izumo S; Berul CI
    J Cardiovasc Electrophysiol; 2002 Jul; 13(7):682-8. PubMed ID: 12139292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac electrophysiological phenotypes in postnatal expression of Nkx2.5 transgenic mice.
    Wakimoto H; Kasahara H; Maguire CT; Moskowitz IP; Izumo S; Berul CI
    Genesis; 2003 Nov; 37(3):144-50. PubMed ID: 14595838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.
    Benson DW; Silberbach GM; Kavanaugh-McHugh A; Cottrill C; Zhang Y; Riggs S; Smalls O; Johnson MC; Watson MS; Seidman JG; Seidman CE; Plowden J; Kugler JD
    J Clin Invest; 1999 Dec; 104(11):1567-73. PubMed ID: 10587520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene.
    Gutierrez-Roelens I; Sluysmans T; Gewillig M; Devriendt K; Vikkula M
    Hum Mutat; 2002 Jul; 20(1):75-6. PubMed ID: 12112663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype?
    Gutierrez-Roelens I; De Roy L; Ovaert C; Sluysmans T; Devriendt K; Brunner HG; Vikkula M
    Eur J Hum Genet; 2006 Dec; 14(12):1313-6. PubMed ID: 16896344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKX2.5 mutations in patients with congenital heart disease.
    McElhinney DB; Geiger E; Blinder J; Benson DW; Goldmuntz E
    J Am Coll Cardiol; 2003 Nov; 42(9):1650-5. PubMed ID: 14607454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in cardiac conduction system lineages and malignant arrhythmias: developmental pathways and disease.
    St Amand TR; Lu JT; Chien KR
    Novartis Found Symp; 2003; 250():260-70; discussion 271-5, 276-9. PubMed ID: 12956335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome.
    Elliott DA; Kirk EP; Yeoh T; Chandar S; McKenzie F; Taylor P; Grossfeld P; Fatkin D; Jones O; Hayes P; Feneley M; Harvey RP
    J Am Coll Cardiol; 2003 Jun; 41(11):2072-6. PubMed ID: 12798584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit.
    Zakariyah AF; Rajgara RF; Veinot JP; Skerjanc IS; Burgon PG
    J Mol Cell Cardiol; 2017 Apr; 105():89-98. PubMed ID: 28302382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
    J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Msx2 does not affect cardiac conduction or rescue conduction defects associated with Nkx2-5 mutation.
    Jay PY; Maguire CT; Wakimoto H; Izumo S; Berul CI
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):82-5. PubMed ID: 15673394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block.
    Pashmforoush M; Lu JT; Chen H; Amand TS; Kondo R; Pradervand S; Evans SM; Clark B; Feramisco JR; Giles W; Ho SY; Benson DW; Silberbach M; Shou W; Chien KR
    Cell; 2004 Apr; 117(3):373-86. PubMed ID: 15109497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease.
    Ikeda Y; Hiroi Y; Hosoda T; Utsunomiya T; Matsuo S; Ito T; Inoue J; Sumiyoshi T; Takano H; Nagai R; Komuro I
    Circ J; 2002 Jun; 66(6):561-3. PubMed ID: 12074273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    Seki A; Ishikawa T; Daumy X; Mishima H; Barc J; Sasaki R; Nishii K; Saito K; Urano M; Ohno S; Otsuki S; Kimoto H; Baruteau AE; Thollet A; Fouchard S; Bonnaud S; Parent P; Shibata Y; Perrin JP; Le Marec H; Hagiwara N; Mercier S; Horie M; Probst V; Yoshiura KI; Redon R; Schott JJ; Makita N
    J Am Coll Cardiol; 2017 Jul; 70(3):358-370. PubMed ID: 28705318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function follows form: cardiac conduction system defects in Nkx2-5 mutation.
    Jay PY; Harris BS; Buerger A; Rozhitskaya O; Maguire CT; Barbosky LA; McCusty E; Berul CI; O'brien TX; Gourdie RG; Izumo S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):966-72. PubMed ID: 15368343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease.
    Stallmeyer B; Fenge H; Nowak-Göttl U; Schulze-Bahr E
    Clin Genet; 2010 Dec; 78(6):533-40. PubMed ID: 20456451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.